Senior Oncology Account Manager
Jazz Pharmaceuticals
Senior Oncology Account Manager
Jazz Pharmaceuticals
Biopharmaceuticals focused on neuroscience and oncology
If you are a current Jazz employee please apply via the Internal Career site
Jazz Pharmaceuticals is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
The Leukemia & Transplant Oncology Account Manager is responsible for direct promotion of Jazz Pharmaceuticals’ products, and the development and management of business relationships with therapeutic specialists within an assigned geographical territory. The Senior Oncology Account Manager (OAM) is an integral part of the commercial team that includes all personnel dedicated to the sales and marketing functions. The Senior Oncology Account Manager will implement Jazz Pharmaceuticals’ marketing strategies and marketing tactics to achieve sales goals through short-term and long-term objectives.
This position reports directly to the Regional Sales Manager. This territory includes Minnesota, Montana, North Dakota, South Dakota, and a portion of western Wisconsin.
Key Skills:
Strategic Account Management:
Teamwork & Collaboration:
Selling Effectiveness:
Product and Scientific Knowledge:
Execution:
Required Experience
Preferred Experience
Description of Physical Demands
#LI-Remote
Jazz Pharmaceuticals is an equal opportunity/affirmative action employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any characteristic protected by law.
FOR US BASED CANDIDATES ONLY
Jazz Pharmaceuticals, Inc. is committed to fair and equitable compensation practices and we strive to provide employees with total compensation packages that are market competitive. For this role, the full and complete base pay range is:
$155,200.00 - $232,800.00Individual compensation paid within this range will depend on many factors, including qualifications, skills, relevant experience, job knowledge, and other pertinent factors. The goal is to ensure fair and competitive compensation aligned with the candidate's expertise and contributions, within the established pay framework and our Total Compensation philosophy. Internal equity considerations will also influence individual base pay decisions. This range will be reviewed on a regular basis.
At Jazz, your base pay is only one part of your total compensation package. The successful candidate may also be eligible for a discretionary annual cash bonus or incentive compensation (depending on the role), in accordance with the terms of the Company's Global Cash Bonus Plan or Incentive Compensation Plan, as well as discretionary equity grants in accordance with Jazz’s Long Term Equity Incentive Plan.
The successful candidate will also be eligible to participate in various benefits offerings, including, but not limited to, medical, dental and vision insurance, 401k retirement savings plan, and flexible paid vacation. For more information on our Benefits offerings please click here: https://careers.jazzpharma.com/benefits.html
Biopharmaceuticals focused on neuroscience and oncology
Jazz Pharmaceuticals is a global biopharmaceutical company focused on neuroscience and oncology, developing and selling therapies for diseases with limited options. Its portfolio includes Xyrem/Xywav for narcolepsy, Epidiolex for seizures, Zepzelca for small cell lung cancer, and Vyxeos for AML. The company grows through a mix of in-house R&D and strategic acquisitions (like GW Pharmaceuticals, Celator, Chimerix) to expand its pipeline. Its goal is to broaden approved therapies and reach patients with limited options by building a diversified, specialty-focused portfolio.
Explore more opportunities at Jazz Pharmaceuticals